FATEFate Therapeutics, Inc.

$143M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$16M

Operating Income

-$25M

Net Income

-$26M

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$51M

Total Liabilities

$23M

Stockholders' Equity

$28M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$971,000	-100.0%
Gross Profit	-$16M	-$11M	-48.9%
Operating Income	-$25M	-$18M	-40.9%
Net Income	-$26M	-$21M	-23.9%

FATE FY 2014 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena